Medicus Sciences Acquisition - Warrants (12/02/2026) OverviewTrack Medicus Sciences Acquisition - Warrants (12/02/2026)'s EBIT ($-700K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022
As of the most recent data (September 2022), MSACW shows a EBIT of $-700K. That is above the sector sector average of $-63M. Scroll down for historical charts and peer comparison views.
The its sector sector average EBIT is about $-63M. Medicus Sciences Acquisition - Warrants (12/02/2026) is at $-700K, which is higher that average. That is roughly 98.9% above the sector mean. Use the comparison chart on this page to see how MSACW stacks up against individual peers as well.
Tracking MSACW's ebit over time shows whether Medicus Sciences Acquisition - Warrants (12/02/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $-700K Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Medicus Sciences Acquisition - Warrants (12/02/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-700K) with ownership activity and broader fundamentals.
